OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION
Por:
Nobre, L, Zapotocky, M, Ramaswamy, V, Ryall, S, Bennet, J, Alderete, D, Guill, JB, Baroni, L, Bartels, U, Bavle, A, Bornhorst, M, Boue', DR, Canete, A, Chintagumpala, M, Coven, SL, Cruz-Martínez O, Dahiya, S, Dirks, P, Dunkel, IJ, Eisenstat, D, Conter, CF, Finch, E, Finlay, JL, Frappaz, D, Garre, ML, Gauvain, K, Bechensteen, AG, Hansford, JR, Harting, I, Hauser, P, Hazrati, LN, Huang, AN, Injac, SG, Iurilli, V, Karajannis, M, Kaur, G, Kyncl, M, Krskova, L, Laperriere, N, Larouche, V, Lassaletta, A, Leary, S, Lin, F, Mascelli, S, McKeown, T, Milde, T, La Madrid, AM, Morana, G, Morse, H, Mushtaq, N, Osorio, DS, Packer, R, Pavelka, Z, Quiroga-Cantero, E, Rutka, J, Sabel, M, Salgado, D, Solano, P, Sterba, J, Su, J, Sumerauer, D, Taylor, MD, Toledano, H, Tsang, DS, Fernandes, MV, van Landeghem, F, van Tilburg, CM, Wilson, B, Witt, O, Zamecbik, J, Bouffet, E, Hawkins, C and Tabori, U
Publicada:
1 dic 2020
Resumen:
Open Access
|